However, in our critically ill patient cohort, patients with and without COVID-19 had similar plasma chemerin levels showing that circulating concentrations of chemerin are raised in patients with severe diseases and are not specifically increased in COVID-19. This evidence concerns the gene RARRES2 and COVID-19.